IISc researchers find Asthma drug Montelukast can block crucial SARS-CoV-2 protein

Approved by the US Food and Drug Administration (FDA), the drug, called montelukast, has been around for more than 20 years and is usually prescribed to reduce inflammation caused by conditions like asthma, hay fever and hives.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Kr5GXho
via IFTTT